Oct 23, 2017 7:00 am EDT Heat Biologics and its Pelican Therapeutics Subsidiary Appoint Two New Members to their Scientific Advisory Boards
Oct 16, 2017 7:00 am EDT Heat Biologics Announces Pricing for Rights Offering to Stockholders and Participating Warrant Holders
Oct 12, 2017 7:00 am EDT UPDATE: Heat Biologics to Present at the Upcoming BIO Investor Forum in San Francisco
Sep 27, 2017 7:00 am EDT Pelican Therapeutics Announces Manufacturing Agreement with KBI Biopharma to Advance Cancer-targeting Immunotherapies
Sep 12, 2017 7:00 am EDT Heat Biologics Granted Type C Meeting with FDA to Discuss Registrational Pathway for HS-110 in Combination with Opdivo(R) as a Treatment for Non-Small Cell Lung Cancer
Sep 07, 2017 7:00 am EDT Heat Biologics to Present at the 19th Annual Rodman & Renshaw Global Investment Conference in New York